NCT02458742

Brief Summary

Pain after transurethral resection of prostate is considered mild to moderate severity from detrusor muscle spasm and traction from urinary catheter. Numerous pain relieve methods have been studied including spinal opioids, spinal anesthesia with local anesthetic and dexmedetomidine, periprostatic nerve blockade with bupivacaine and mixing of prilocaine with distilled water irrigation while undergoing a procedure. Most of patients having this procedure are in elderly period, thus many anesthetists avoided spinal morphine which may cause respiratory depressant effect postoperatively. Although previous studies showed effectiveness of spinal morphine 25-200 mcg, some patients suffered from neuraxial opioid side effects. The aim of this study is to demonstrate efficacy of local anesthetic with intrathecal morphine 50 mcg providing pain relieve after transurethral resection of prostate compare to spinal anesthesia with sole local anesthetic.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 1, 2015

Completed
Same day until next milestone

Study Start

First participant enrolled

June 1, 2015

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

January 15, 2019

Status Verified

January 1, 2019

Enrollment Period

1.2 years

First QC Date

May 28, 2015

Last Update Submit

January 14, 2019

Conditions

Keywords

spinal anesthesiaintrathecal morphinetransurethral resection of prostatepostoperative pain

Outcome Measures

Primary Outcomes (1)

  • Numerical rating scale (0-10)

    Pain score rating by numerical rating scale in 24-hr postoperative

    24 hours postoperatively

Secondary Outcomes (3)

  • Requirement of rescue pain

    24 hours postoperatively

  • Adverse effects

    24 hours postoperatively

  • Satisfaction score

    24 hours postoperatively

Study Arms (2)

Morphine

EXPERIMENTAL

0.5%Bupivacaine 2 ml with morphine 50 mcg for spinal anesthesia

Drug: Morphine

Placebo

PLACEBO COMPARATOR

0.5%Bupivacaine 2 ml for spinal anesthesia

Drug: Placebo

Interventions

0.5%Hyperbaric bupivacaine 2 ml add morphine 50 mcg for spinal anesthesia

Also known as: Hyperbaric bupivacaine with morphine
Morphine

0.5%Hyperbaric bupivacaine 2 ml for spinal anesthesia

Also known as: Hyperbaric bupivacaine
Placebo

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> or = 18 years old
  • Undergoing transurethral resection of prostate gland

You may not qualify if:

  • Contraindication for spinal anesthesia for any reasons eg. infection, bleeding disorder
  • Refuse spinal anesthesia
  • Allergic to study drugs
  • History of cerebrovascular disease or stroke

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (8)

  • Kose O, Saglam HS, Altun ME, Sonbahar T, Kumsar S, Adsan O. Prilocaine irrigation for pain relief after transurethral resection of the prostate. J Endourol. 2013 Jul;27(7):892-5. doi: 10.1089/end.2013.0001. Epub 2013 Jun 12.

    PMID: 23565930BACKGROUND
  • Gorur S, Inanoglu K, Akkurt BC, Candan Y, Kiper AN. Periprostatic nerve blockage reduces postoperative analgesic consumption and pain scores of patients undergoing transurethral prostate resection. Urol Int. 2007;79(4):297-301. doi: 10.1159/000109712.

    PMID: 18025845BACKGROUND
  • Kim JE, Kim NY, Lee HS, Kil HK. Effects of intrathecal dexmedetomidine on low-dose bupivacaine spinal anesthesia in elderly patients undergoing transurethral prostatectomy. Biol Pharm Bull. 2013;36(6):959-65. doi: 10.1248/bpb.b12-01067.

    PMID: 23727917BACKGROUND
  • Suksompong S, Pongpayuha P, Lertpaitoonpan W, von Bormann B, Phanchaipetch T, Sanansilp V. Low-dose spinal morphine for post-thoracotomy pain: a prospective randomized study. J Cardiothorac Vasc Anesth. 2013 Jun;27(3):417-22. doi: 10.1053/j.jvca.2012.12.003. Epub 2013 Mar 29.

    PMID: 23545346BACKGROUND
  • Duman A, Apiliogullari S, Balasar M, Gurbuz R, Karcioglu M. Comparison of 50 microg and 25 microg doses of intrathecal morphine on postoperative analgesic requirements in patients undergoing transurethral resection of the prostate with intrathecal anesthesia. J Clin Anesth. 2010 Aug;22(5):329-33. doi: 10.1016/j.jclinane.2009.09.006.

    PMID: 20650378BACKGROUND
  • Kirson LE, Goldman JM, Slover RB. Low-dose intrathecal morphine for postoperative pain control in patients undergoing transurethral resection of the prostate. Anesthesiology. 1989 Aug;71(2):192-5. doi: 10.1097/00000542-198908000-00004.

    PMID: 2667399BACKGROUND
  • Ozbek H, Deniz MN, Erakgun A, Erhan E. Comparison of 75 and 150 mug doses of intrathecal morphine for postoperative analgesia after transurethral resection of the prostate under spinal anesthesia. J Opioid Manag. 2013 Nov-Dec;9(6):415-20. doi: 10.5055/jom.2013.0184.

    PMID: 24481930BACKGROUND
  • Sakai T, Use T, Shimamoto H, Fukano T, Sumikawa K. Mini-dose (0.05 mg) intrathecal morphine provides effective analgesia after transurethral resection of the prostate. Can J Anaesth. 2003 Dec;50(10):1027-30. doi: 10.1007/BF03018367.

    PMID: 14656781BACKGROUND

MeSH Terms

Conditions

AgnosiaPain, Postoperative

Interventions

Morphine

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsPostoperative ComplicationsPathologic ProcessesPain

Intervention Hierarchy (Ancestors)

Morphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic Compounds

Study Officials

  • Pawinee Pangthipampai, M.D.

    Siriraj Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2015

First Posted

June 1, 2015

Study Start

June 1, 2015

Primary Completion

August 1, 2016

Study Completion

September 1, 2016

Last Updated

January 15, 2019

Record last verified: 2019-01